111 related articles for article (PubMed ID: 30277515)
1. psichomics: graphical application for alternative splicing quantification and analysis.
Saraiva-Agostinho N; Barbosa-Morais NL
Nucleic Acids Res; 2019 Jan; 47(2):e7. PubMed ID: 30277515
[TBL] [Abstract][Full Text] [Related]
2. 3D RNA-seq: a powerful and flexible tool for rapid and accurate differential expression and alternative splicing analysis of RNA-seq data for biologists.
Guo W; Tzioutziou NA; Stephen G; Milne I; Calixto CP; Waugh R; Brown JWS; Zhang R
RNA Biol; 2021 Nov; 18(11):1574-1587. PubMed ID: 33345702
[TBL] [Abstract][Full Text] [Related]
3. betAS: intuitive analysis and visualization of differential alternative splicing using beta distributions.
Ascensão-Ferreira M; Martins-Silva R; Saraiva-Agostinho N; Barbosa-Morais NL
RNA; 2024 Mar; 30(4):337-353. PubMed ID: 38278530
[TBL] [Abstract][Full Text] [Related]
4. SpliceWiz: interactive analysis and visualization of alternative splicing in R.
Wong ACH; Wong JJ; Rasko JEJ; Schmitz U
Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38152981
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing.
Jiang W; Chen L
Comput Struct Biotechnol J; 2021; 19():183-195. PubMed ID: 33425250
[TBL] [Abstract][Full Text] [Related]
6. QUANTIFYING ALTERNATIVE SPLICING FROM PAIRED-END RNA-SEQUENCING DATA.
Rossell D; Stephan-Otto Attolini C; Kroiss M; Stöcker A
Ann Appl Stat; 2014 Mar; 8(1):309-330. PubMed ID: 24795787
[TBL] [Abstract][Full Text] [Related]
7. HBA-DEALS: accurate and simultaneous identification of differential expression and splicing using hierarchical Bayesian analysis.
Karlebach G; Hansen P; Veiga DF; Steinhaus R; Danis D; Li S; Anczukow O; Robinson PN
Genome Biol; 2020 Jul; 21(1):171. PubMed ID: 32660516
[TBL] [Abstract][Full Text] [Related]
8. Alternative RNA splicing generates shared clonal neoantigens across different types of cancer.
Brown M; Vabret N
Nat Rev Immunol; 2024 Mar; 24(3):160. PubMed ID: 38216760
[No Abstract] [Full Text] [Related]
9. Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase.
Yuan J; Ma Y; Huang T; Chen Y; Peng Y; Li B; Li J; Zhang Y; Song B; Sun X; Ding Q; Song Y; Chang X
Mol Cell; 2018 Oct; 72(2):380-394.e7. PubMed ID: 30293782
[TBL] [Abstract][Full Text] [Related]
10. CancerSplicingQTL: a database for genome-wide identification of splicing QTLs in human cancer.
Tian J; Wang Z; Mei S; Yang N; Yang Y; Ke J; Zhu Y; Gong Y; Zou D; Peng X; Wang X; Wan H; Zhong R; Chang J; Gong J; Han L; Miao X
Nucleic Acids Res; 2019 Jan; 47(D1):D909-D916. PubMed ID: 30329095
[TBL] [Abstract][Full Text] [Related]
11. ASGAL: aligning RNA-Seq data to a splicing graph to detect novel alternative splicing events.
Denti L; Rizzi R; Beretta S; Vedova GD; Previtali M; Bonizzoni P
BMC Bioinformatics; 2018 Nov; 19(1):444. PubMed ID: 30458725
[TBL] [Abstract][Full Text] [Related]
12. An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.
Ruta V; Naro C; Pieraccioli M; Leccese A; Archibugi L; Cesari E; Panzeri V; Allgöwer C; Arcidiacono PG; Falconi M; Carbone C; Tortora G; Borrelli F; Attili F; Spada C; Quero G; Alfieri S; Doglioni C; Kleger A; Capurso G; Sette C
Cell Rep Med; 2024 Feb; 5(2):101411. PubMed ID: 38325381
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
Webster NJG; Kumar D; Wu P
Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
[TBL] [Abstract][Full Text] [Related]
14.
Gallego-Paez LM; Mauer J
Front Bioinform; 2022; 2():786898. PubMed ID: 36304260
[TBL] [Abstract][Full Text] [Related]
15. FOXA1 regulates alternative splicing in prostate cancer.
Del Giudice M; Foster JG; Peirone S; Rissone A; Caizzi L; Gaudino F; Parlato C; Anselmi F; Arkell R; Guarrera S; Oliviero S; Basso G; Rajan P; Cereda M
Cell Rep; 2022 Sep; 40(13):111404. PubMed ID: 36170835
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection.
Luo Z; Li M; Li TW; Lv Z; Ye Z; Cisneros WJ; Zhang J; Yuan L; Hultquist JF; Migueles SA; Huang L; Zhu J; Jiang W
mBio; 2022 Feb; 13(1):e0197921. PubMed ID: 35041523
[TBL] [Abstract][Full Text] [Related]
18. Effects of alternative splicing events and transcriptome changes on kidney stone formation.
Yan Q; Chen Y; Liu H; Li G; Liang C; Hao Z
Urolithiasis; 2022 Apr; 50(2):131-140. PubMed ID: 34997271
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
Naro C; De Musso M; Delle Monache F; Panzeri V; de la Grange P; Sette C
J Exp Clin Cancer Res; 2021 Dec; 40(1):397. PubMed ID: 34930366
[TBL] [Abstract][Full Text] [Related]
20. Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer.
Namba S; Ueno T; Kojima S; Kobayashi K; Kawase K; Tanaka Y; Inoue S; Kishigami F; Kawashima S; Maeda N; Ogawa T; Hazama S; Togashi Y; Ando M; Shiraishi Y; Mano H; Kawazu M
Commun Biol; 2021 Nov; 4(1):1320. PubMed ID: 34811492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
